Julie McHugh
CIK 1487179 · Chief Operating Officer · last filed 2026-06-17
Julie McHugh is a Chief Operating Officer who has filed 86 SEC Form 4 insider transactions across 8 companies since 2011. The most recent filing, for IRWD, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.04M
8
86
-$2.17M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRWD | Director | 250,749 | $3.80 | $952.8K | -$827.2K | 26 | 2026-06-17 |
| LNTH | Director | 30,099 | $102.64 | $3.09M | -$1.34M | 22 | 2026-05-18 |
| Evelo Biosciences, Inc. (EVLO) Delisted | Director | — | $0.00 | — | $0 | 3 | 2023-06-12 |
| AERIE PHARMACEUTICALS INC (AERI) Delisted | Director | 0 | $15.25 | $0 | $0 | 9 | 2022-11-21 |
| TREVENA INC (TRVN) Delisted | Director | — | $0.01 | — | $0 | 7 | 2020-05-15 |
| EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Director | — | — | — | $0 | 2 | 2015-06-08 |
| VIROPHARMA INC (VPHM) Delisted | Director | 8,666 | — | — | $0 | 5 | 2014-01-03 |
| ENDO HEALTH SOLUTIONS INC. (ENDP) Delisted | Chief Operating Officer | 48,046 | $0.29 | $14.1K | $0 | 7 | 2013-03-15 |
Recent Filings
86 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-17 | IRWD | Mixed | +41,910 | -$80.5K | EDGAR |
| 2026-06-16 | IRWD | Notice (144) | −21,571 | -$79.6K | EDGAR |
| 2026-05-18 | LNTH | Grant (A) | +4,137 | $0 | EDGAR |
| 2025-06-12 | IRWD | Grant (A) | +45,000 | $0 | EDGAR |
| 2025-06-11 | LNTH | Sell (S) | −5,192 | -$423.8K | EDGAR |
| 2025-06-09 | LNTH | Notice (144) | −5,192 | -$423.8K | EDGAR |
| 2025-05-16 | LNTH | Grant (A) | +2,537 | $0 | EDGAR |
| 2024-06-21 | IRWD | Grant (A) | +24,311 | $0 | EDGAR |
| 2024-06-12 | IRWD | Sell (S) | −22,766 | -$143.2K | EDGAR |
| 2024-06-10 | IRWD | Notice (144) | −22,766 | -$144.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.